Poster Abstract Session:
166. Pneumococcal Immunization in Adults
Friday, October 6, 2017: 12:30 PM-2:00 PM
Room: Poster Hall CD


Presentations:
Excess Risk of Invasive Pneumococcal Disease (IPD) Persists in Adults with Comorbid Conditions in the Era of PCV13 Childhood and Adult Immunization
Stephen I. Pelton, MD; Rebecca Bornheimer, BA; Kimberly M. Shea, PhD, MPH; Reiko Sato, PhD; Derek Weycker, PhD
Distributions and Annual Changes of Streptococcus pneumoniae Serotypes Causing Infections in Adult Patients: Eight Years of US Surveillance (2009-2016)
Rodrigo E. Mendes, Ph.D.; Heather L. Sings, PhD; Betsy Hilton, BSN, MSHS; Timothy P. Doyle, MS; Leah N. Woosley, B.S.; Robert K. Flamm, PhD; Raúl E. Isturiz, MD
Disparities in Uptake of 13-valent Pneumococcal Conjugate Vaccine among Older Adults Following Routine Recommendation in the United States
John McLaughlin, PhD; Farid Khan, MPH; Aaron Curry, PhD; Vincenza Snow, MD; Raúl Isturiz, MD; David Swerdlow, MD
Implementing Pneumococcal Vaccination in Hospitalized Adults With COPD, Asthma, Current Smokers, And/Or Over Age 65 years. A Performance Improvement Project.
Saad Bin Jamil, MD; Faran Ahmad, MD; Ajay Patel, MD; Shruti Polo, MD; Talat Syed, MD; Shakera Syed, MD; Theodore Casper, MD; Ts Dharmarajan, MD/ FACP/AGSF
Posters
  • IDSA.pdf (4.9 MB)
  • Sequential administration of PCV13 followed by PPSV23 results in a more robust immune response in PPSV23-naïve adults age 60-64 years
    Erica Chilson, PharmD; Bruce Atkinson, PhD; Cassandra Hall-Murray, PharmD; Vincenza Snow, MD; Beate Schmoele-Thoma, MD; Raúl E. Isturiz, MD; Daniel A. Scott, MD
    Posters
  • Sequentialadmin.pdf (563.6 kB)
  • Efficacy of Influenza and Pneumococcal Vaccination In Preventing COPD Exacerbation
    Azharul Haque, MBBS; Azeez Ameer, MD; Rajalakshmi Ananthanarayanan, MBBS, DNB; Arjun Padmanabhan, MD
    Posters
  • vaccine poster, IDSA.pdf (134.1 kB)
  • CME Credits: Maximum of 0.00 hours of AMA PRA Category 1 Credit™


    Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 4th with the exception of research findings presented at the IDWeek press conferences.